Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Iradimed (IRMD) Accumulated Depreciation & Amortization (2016 - 2026)

Iradimed has reported Accumulated Depreciation & Amortization over the past 14 years, most recently at $455000.0 for Q1 2026.

  • Quarterly Accumulated Depreciation & Amortization rose 134.54% to $455000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $455000.0 through Mar 2026, up 134.54% year-over-year, with the annual reading at $5.1 million for FY2025, 10.38% up from the prior year.
  • Accumulated Depreciation & Amortization was $455000.0 for Q1 2026 at Iradimed, down from $5.1 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $5.1 million in Q4 2025 and troughed at $134870.0 in Q1 2022.
  • The 5-year median for Accumulated Depreciation & Amortization is $569551.0 (2022), against an average of $2.3 million.
  • Year-over-year, Accumulated Depreciation & Amortization soared 2609.78% in 2024 and then plummeted 95.38% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $569551.0 in 2022, then surged by 614.57% to $4.1 million in 2023, then increased by 12.9% to $4.6 million in 2024, then increased by 10.38% to $5.1 million in 2025, then crashed by 91.03% to $455000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Accumulated Depreciation & Amortization are $455000.0 (Q1 2026), $5.1 million (Q4 2025), and $4.9 million (Q3 2025).